1. Home
  2. GVH vs CDT Comparison

GVH vs CDT Comparison

Compare GVH & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

HOLD

Current Price

$1.23

Market Cap

2.7M

Sector

N/A

ML Signal

HOLD

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$1.07

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVH
CDT
Founded
2016
2019
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GVH
CDT
Price
$1.23
$1.07
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$80.00
N/A
AVG Volume (30 Days)
177.6K
120.7K
Earning Date
01-30-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
11.95
N/A
Revenue
$21,878,867.00
N/A
Revenue This Year
$141,706.20
N/A
Revenue Next Year
$3.35
N/A
P/E Ratio
$0.10
N/A
Revenue Growth
24.52
N/A
52 Week Low
$1.09
$1.06
52 Week High
$364.00
$444.00

Technical Indicators

Market Signals
Indicator
GVH
CDT
Relative Strength Index (RSI) 33.08 31.43
Support Level $1.17 $1.07
Resistance Level $1.29 $1.59
Average True Range (ATR) 0.11 0.11
MACD 0.08 -0.02
Stochastic Oscillator 34.21 2.15

Price Performance

Historical Comparison
GVH
CDT

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: